Interestingly, METTL14 can enhance DROSHA mRNA stability by catalyzing the m6A modification, indicating that targeting the METTL14-DROSHA-β-Catenin axis might impair breast cancer progression [44]. The gene discussed is METTL14; the disease is breast carcinoma.